Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 hours agoBiotech stock hit a two-year high in February, but have trended lower in the months since despite a...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 5 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoSo, all in all, is PFE stock a buy or a sell right now? Pfizer Stock Fundamentals: 'Massive' Upside...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 7 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Cancer vaccine hailed as 'game-changer'
Newsweek· 2 hours agoCancer patients in the U.K. are about to get personalized cancer vaccines as part of a new trial. Unlike vaccines for diseases like the flu or COVID-19,...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 2 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 5 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
New U.S. bird-flu case is first with respiratory symptoms, CDC says
Market Watch· 20 hours agoA new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 7 days agoAl Shams holds 6,513,000 shares, or 9.8% of Braemar’s shares outstanding. This follows the sale of 50,000 shares from April 17 through April 18 at prices...
